Expertise in
3
conditions

Dr. Marina F. Caskey

Infectious Disease
Weill Cornell Medicine - Infectious Diseases
1315 York Ave, 
New York, NY 
Expertise in
3
conditions
Weill Cornell Medicine - Infectious Diseases
1315 York Ave, 
New York, NY 

Overview

Marina Caskey is an Infectious Disease provider practicing medicine in New York, New York.

Dr. Caskey is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Sepsis, and Pneumonia.

She is actively involved in clinical research, co-authoring 135 peer reviewed articles and participating in 6 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in NY

Hospital Affiliations

New York-Presbyterian Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Weill Cornell Medicine - Infectious Diseases
1315 York Ave, New York, NY 10021

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 1 First-in-human Study of the Safety and Pharmacokinetics of 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
A Phase 1 First-in-human Study of the Safety and Pharmacokinetics of 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
Enrollment Status: Completed
Publish Date: May 20, 2026
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Randomized Study of the Safety and Antiretroviral Activity of 3BNC117 and 10-1074 in HIV-infected Individuals on Combination Antiretroviral Therapy and During Analytical Treatment Interruption.
An Open Label, Randomized Study of the Safety and Antiretroviral Activity of 3BNC117 and 10-1074 in HIV-infected Individuals on Combination Antiretroviral Therapy and During Analytical Treatment Interruption.
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Other, Drug
Study Drugs: 3BNC117, 10-1074
Study Phase: Phase 1
An Open Label, Single Arm Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals.
An Open Label, Single Arm Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals.
Enrollment Status: Completed
Publish Date: June 26, 2023
Intervention Type: Drug
Study Drugs: 3BNC117-LS, 10-1074-LS
Study Phase: Phase 1
A Phase 2a, Randomized Study of Romidepsin With or Without 3BNC117 to Evaluate the Effects on the HIV-1 Reservoir (ROADMAP)
A Phase 2a, Randomized Study of Romidepsin With or Without 3BNC117 to Evaluate the Effects on the HIV-1 Reservoir (ROADMAP)
Enrollment Status: Completed
Publish Date: July 14, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1, Dose Escalation, First-in-human Study of the Safety and Pharmacokinetics of the Subcutaneous and Intravenous Administration of 10-1074-LS Alone and in Combination With 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
A Phase 1, Dose Escalation, First-in-human Study of the Safety and Pharmacokinetics of the Subcutaneous and Intravenous Administration of 10-1074-LS Alone and in Combination With 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
Enrollment Status: Completed
Publish Date: August 04, 2021
Intervention Type: Drug
Study Drugs: 10-1074-LS, 3BNC117-LS
Study Phase: Phase 1
An Phase 1b Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117 and 10-1074 in HIV-infected Individuals
An Phase 1b Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117 and 10-1074 in HIV-infected Individuals
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Other, Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

135 Total Publications

Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B.
Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Similar Doctors
Expertise in
12
conditions
Dr. Jihad S. Slim
Infectious Disease
Expertise in
12
conditions
Dr. Jihad S. Slim
Infectious Disease
Referral may be required

Saint Michael's Medical Center

111 Central Ave, 
Newark, NJ 
 (11.6 miles away)
973-877-5644
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Jihad Slim is an Infectious Disease provider practicing medicine in Newark, New Jersey. Dr. Slim is highly rated in 12 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, COVID-19, Hepatitis, and Gastrostomy. Dr. Slim is currently accepting new patients.

Expertise in
6
conditions
Dr. Genovefa A. Papanicolaou
Infectious Disease
Expertise in
6
conditions
Dr. Genovefa A. Papanicolaou
Infectious Disease
Referral may be required

David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center

530 E 74th St, 
New York, NY 
 (0.2 miles away)
929-476-0294
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Genovefa Papanicolaou is an Infectious Disease provider practicing medicine in New York, New York. Dr. Papanicolaou is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Cytomegalovirus Infection, Sepsis, Cytomegalic Inclusion Disease, and Pneumonia.

Expertise in
9
conditions
Dr. Gary P. Wormser
Infectious Disease
Expertise in
9
conditions
Dr. Gary P. Wormser
Infectious Disease
Referral may be required

Westchester County Health Care Corporation

100 Woods Rd, 
Valhalla, NY 
 (23.6 miles away)
914-493-7000
Languages Spoken:
English
See accepted insurances

Gary Wormser is an Infectious Disease provider practicing medicine in Valhalla, New York. Dr. Wormser is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lyme Disease, Babesiosis, Human Granulocytic Ehrlichiosis, Ehrlichiosis, and Splenectomy.

Frequently Asked Questions about Dr. Marina F. Caskey

How do I make an appointment with Dr. Marina F. Caskey?

You can book an appointment with Dr. Marina F. Caskey by calling their office at 347-719-7640. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marina F. Caskey a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marina F. Caskey is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marina F. Caskey specialize in?

While Dr. Marina F. Caskey is a Infectious Disease, they have specific expertise in HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Sepsis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Marina F. Caskey participate in research or clinical trials?

Yes. Dr. Marina F. Caskey has published 135 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Marina F. Caskey's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marina F. Caskey accept my insurance?

Dr. Marina F. Caskey accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 347-719-7640 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Caskey's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile